Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

swissinfo.ch - Aanu Adeoye - Big Pharma's race to stop Alzheimer's before it starts
Big Pharma's race to stop Alzheimer's before it starts
www.swissinfo.ch –

Carole Greig was working as a companion to women living with dementia when she began to experience problems with her own short-term memory. The 71-year-old former bank employee was herself diagnosed with Alzheimer's disease in 2023: a terrible…

fool.com - Sara Appino - Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
The Motley Fool –

Investors choosing between VanEck Pharmaceutical ETF (PPH +1.11%) and iShares Biotechnology ETF (IBB -0.44%) are weighing a concentrated, dividend-paying basket of drugmakers against a broader, more volatile portfolio of biotech innovators. The…

fool.com - Sara Appino - Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?
Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?
The Motley Fool –

State Street SPDR S&P Pharmaceuticals ETF (XPH -0.28%) and iShares Biotechnology ETF (IBB -0.44%) both offer targeted healthcare exposure, but they differ significantly in sub-sector focus, asset size, and cost structure. Healthcare investors often…

marketbeat.com - FY2026 EPS Estimate for Spyglass Pharma Decreased by Analyst
FY2026 EPS Estimate for Spyglass Pharma Decreased by Analyst
MarketBeat –

Spyglass Pharma, Inc. (NASDAQ:SGP - Free Report) - Analysts at HC Wainwright decreased their FY2026 earnings per share (EPS) estimates for Spyglass Pharma in a research note issued on Thursday, November 12th. HC Wainwright analyst Y. Chen now…

marketbeat.com - Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Rated 'Moderate Buy' by Wall Street Brokerages
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Rated 'Moderate Buy' by Wall Street Brokerages
MarketBeat –

Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) has been assigned an average rating of 'Moderate Buy' from the nine analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Stock Has Consensus Price Target of $313.52
Ascendis Pharma A/S (NASDAQ:ASND) Stock Has Consensus Price Target of $313.52
MarketBeat –

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has received an average recommendation of 'Moderate Buy' from the twenty-one analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a…

thehindu.com -  The Hindu Bureau - Telangana government urged to clear fee reimbursement dues of pharmacy colleges
Telangana government urged to clear fee reimbursement dues of pharmacy colleges
The Hindu –

The Telangana Pharmacy Colleges Managements Association, comprising 120 private colleges and 3 government colleges, with approximately 70,000 students, has urged the government to clear the fee reimbursement dues that are meagre compared to others.

fool.com - Robert Izquierdo - Better Healthcare ETF: Invesco's PJP vs. Simplify's PINK
Better Healthcare ETF: Invesco's PJP vs. Simplify's PINK
The Motley Fool –

Comparing the Simplify Health Care ETF (PINK +0.13%) and Invesco Pharmaceuticals ETF (PJP +0.41%) reveals distinct approaches to healthcare, with PINK focusing on broad innovation through active management and PJP offering concentrated exposure to…

cbsnews.com - Jon  Wertheim - Parents whose sons died from kratom use warn about the substance finding allies in Washington
Parents whose sons died from kratom use warn about the substance finding allies in Washington
CBS News –

Kratom, a substance that acts on opioid receptors, can be as easy to obtain as a bag of chips. Kratom is derived from a tree native to Southeast Asia, where for generations people have chewed the leaves or boiled them to make a stimulating tea with…

seekingalpha.com - High Alpha Professor - Kura Oncology: JNJ's Bleximenib Is A Serious Threat, But Kura Still Has A Fighting Chance
Kura Oncology: JNJ's Bleximenib Is A Serious Threat, But Kura Still Has A Fighting Chance
Seeking Alpha –

Kura Oncology is a cautious Hold: my $6.75 valuation implies roughly 10% downside, balanced against an established market presence and combination potential. JNJ's bleximenib showed stronger remission and response-duration metrics, complicating…

cbsnews.com - Jon  Wertheim - 60 Minutes Transcript: Kratom, often sold as an herbal supplement, can pose serious health risks
60 Minutes Transcript: Kratom, often sold as an herbal supplement, can pose serious health risks
CBS News –

Over the next two weeks, we bring you a special report on the status of the American opioid crisis that's claimed nearly a million casualties and is far from over. We start with kratom. You've probably seen the signs advertising kratom, a substance…

hoodline.com - Nolan Keegan - Reuters NEXT New York 2026: Dates, Speakers, Lineup
Reuters NEXT New York 2026: Dates, Speakers, Lineup
Hoodline –

Reuters has unveiled the speaker lineup for its annual Reuters NEXT leadership summit, set to return to New York for two days starting December 1, 2026. The invitation-only gathering is expected to bring together 600+ CEOs and global decision…

fool.com - Sara Appino - Which Healthcare ETF Is Best for the Long Term: State Street's XPH or Invesco's PBE?
Which Healthcare ETF Is Best for the Long Term: State Street's XPH or Invesco's PBE?
The Motley Fool –

The State Street SPDR S&P Pharmaceuticals ETF (XPH -0.28%) offers broader exposure and lower expenses, while the Invesco Biotechnology & Genome ETF (PBE -0.56%) provides a concentrated, higher-yielding strategy focused on biotech momentum.

marketbeat.com - Best Growth Stocks To Add to Your Watchlist - November 15th
Best Growth Stocks To Add to Your Watchlist - November 15th
MarketBeat –

Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies…

marketbeat.com - Teva Pharmaceutical Industries Ltd. $TEVA Stock Purchased by Migdal Insurance & Financial Holdings Ltd.
Teva Pharmaceutical Industries Ltd. $TEVA Stock Purchased by Migdal Insurance & Financial Holdings Ltd.
MarketBeat –

Migdal Insurance & Financial Holdings Ltd. increased its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 1.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The…

Receive a Daily briefing on Pharma Industry News

Get Started